If You’re An Adventuresome Investor, Then Take A Chance On Stoke Therapeutics Inc (NASDAQ: STOK)
In today’s recent session, 0.8 million shares of the Stoke Therapeutics Inc (NASDAQ:STOK) have been traded, and its beta is 0.79. Most recently the company’s